Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CACNA1C | Q13936 | 11/20 | 0.58 |
| ▸ | CACNA1F | O60840 | 9/20 | 0.54 |
| ▸ | CACNA1D | Q01668 | 9/20 | 0.54 |
| ▸ | CACNA1S | Q13698 | 9/20 | 0.54 |
| ▸ | ADORA3 | P0DMS8 | 4/20 | 0.54 |
| ▸ | MAPT | P10636 | 5/20 | 0.53 |
| ▸ | HIF1A | Q16665 | 4/20 | 0.53 |
| ▸ | CYP1A2 | P05177 | 4/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.53 |
| ▸ | LMNA | P02545 | 4/20 | 0.53 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.53 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.53 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.53 |
| ▸ | MEN1 | O00255 | 3/20 | 0.53 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.53 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.53 |
| ▸ | TSHR | P16473 | 2/20 | 0.53 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.53 |
| ▸ | THPO | P40225 | 2/20 | 0.53 |
| ▸ | POLB | P06746 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9136064 | 0.85 | KDM4E (0.50) | CACNA1CCACNA1FCACNA1DCACNA1SADORA3 | |
| SCHEMBL12716471 | 0.85 | KDM4E (0.50) | CACNA1CMAPTKMT2AMEN1CYP2D6 | |
| SCHEMBL18191095 | 0.84 | ALDH1A1 (0.43) | CACNA1CCACNA1FCACNA1DCACNA1SADORA3 | |
| SCHEMBL9831174 | 0.81 | CACNA1C (0.71) | CACNA1CCACNA1FCACNA1DCACNA1SADORA3 | |
| SCHEMBL1617472 | 0.79 | CACNA1C (0.77) | CACNA1CCACNA1FCACNA1DCACNA1SADORA3 | |
| SCHEMBL29810716 | 0.79 | CACNA1C (0.77) | CACNA1CCACNA1FCACNA1DCACNA1SADORA3 | |
| SCHEMBL5085498 | 0.78 | ADORA3 (0.86) | CACNA1CCACNA1FCACNA1DCACNA1SADORA3 | |
| SCHEMBL3054611 | 0.77 | CACNA1C (0.76) | CACNA1CCACNA1FCACNA1DCACNA1SADORA3 | |
| SCHEMBL10377686 | 0.77 | MAPT (0.47) | MAPTCYP1A2KMT2ACYP3A4CYP2C9 | |
| SCHEMBL11691221 | 0.76 | KDM4E (0.56) | MAPTCYP1A2KMT2ACYP3A4CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10813831-B2 | Medical bathing device | BSN MEDICAL GMBH (DE) | 2020-10-27 | — | — | US | disclosed |
| EP-1934561-B1 | IMPROVED TIME/TEMPERATURE INDICATORS | SUN CHEMICAL CORP (US) | 2018-11-07 | — | — | EP | disclosed |
| US-20180153768-A1 | MEDICAL BATHING DEVICE | BSN MEDICAL GMBH (DE) | 2018-06-07 | — | — | US | disclosed |
| US-20130230648-A1 | KIT OF PARTS FOR CURABLE COATING COMPOSITION | AKZO NOBEL COATINGS INTERNATIONAL B.V. (NL) | 2013-09-05 | — | — | US | disclosed |
| EP-1963392-B2 | MULTILAYER COATING SYSTEM | AKZO NOBEL COATINGS INT BV (NL) | 2012-08-01 | — | — | EP | disclosed |
| US-20120107519-A1 | RADIATION CURING OF COATINGS | AKZO NOBEL COATINGS INTERNATIONAL B.V. (NL) | 2012-05-03 | — | — | US | disclosed |
| US-7923113-B2 | Shorter drying times; clear coats; addition of a basic catalyst; isocyanate-functional compound and thiol-functional compound; useful in repair and refinish of automobiles | AKZO NOBEL COATING INTERNATIONAL B.V. (NL) | 2011-04-12 | — | — | US | disclosed |
| US-7709555-B2 | coatings comprising polythiols, polyisocyanates and moisture activatable latent base catalysts, used as concrete floor coatings, car repair primers or clear coats | AKZO NOBEL COATINGS INTERNATIONAL (NL) | 2010-05-04 | — | — | US | disclosed |
| EP-1963392-B1 | MULTILAYER COATING SYSTEM | AKZO NOBEL COATINGS INT BV (NL) | 2009-08-05 | — | — | EP | disclosed |
| US-20090142600-A1 | MULTILAYER COATING SYSTEM | AKZO NOBEL COATINGS INTERNATIONAL B.V. (NL) | 2009-06-04 | — | — | US | disclosed |
| EP-1789464-B1 | COATING COMPOSITION BASED ON THIOL-NCO CURING | AKZO NOBEL COATINGS INT BV (NL) | 2008-11-05 | — | — | EP | disclosed |
| US-20080269050-A1 | Time/Temperature Indicators | SUN CHEMICAL CORPORATION (US) | 2008-10-30 | — | — | US | disclosed |
| US-20080194720-A1 | Coating Composition Based on Thiol-Nco Curing | AKZO NOBEL COATINGS INTERNATIONAL B.V. (NL) | 2008-08-14 | — | — | US | disclosed |
| US-20070202341-A1 | Multilayer Coating System | AKZO NOBEL COATINGS INTERNATIONAL B.V. (NL) | 2007-08-30 | — | — | US | disclosed |
| EP-1285012-B1 | PHOTOACTIVATABLE COATING COMPOSITION | AKZO NOBEL COATINGS INT BV (NL) | 2007-01-10 | — | — | EP | disclosed |
| US-6867244-B2 | Photoactivatable coating composition | AKZO NOBEL N.V. (NL) | 2005-03-15 | — | — | US | disclosed |
| US-20030212164-A1 | Photoactivatable coating composition | AKZO NOBEL N.V. (NL) | 2003-11-13 | — | — | US | disclosed |
| US-6579913-B2 | Polyisocyanate and a compound comprising isocyanate reactive groups comprising at least one thiol group; photolatent basic photoinitiator | AKZO NOBEL N.V. (NL) | 2003-06-17 | — | — | US | disclosed |
| US-20020032248-A1 | Photoactivatable coating composition | AKZO NOBEL N.V. (NL) | 2002-03-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180153768-A1 | MEDICAL BATHING DEVICE | NOS1, NOS2, POLR1C | CACNA1C 1868/4885CACNA1F 3181/4885CACNA1D 2445/4885 |
| US-10813831-B2 | Medical bathing device | NOS1, NOS2, POLR1C | CACNA1C 1868/4885CACNA1F 3181/4885CACNA1D 2445/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.